2026. Recent Advancements in Ex Vivo CRISPR/Cas9 Gene Editing for Hemoglobinopathies: A Systematic Review of Clinical and Preclinical Progress. Al-Shatrah Veterinary and Biological Sciences Journal. 2, 3 (Jun. 2026), 98–113.